Single US Guided HA Injection Reduced Hip Pain and Improved Function for 20 Months: A Case of Osteonecrosis

Moustafa, Asmaa Mahmoud Ali

doi:10.24966/orp-2052/100029

ORP

2017

DOI: 10.24966/orp-2052/100029

|View full text |Cite

Single US Guided HA Injection Reduced Hip Pain and Improved Function for 20 Months: A Case of Osteonecrosis

Asmaa Mahmoud Ali Moustafa¹

Abstract: BackgroundOsteonecrosis (ON) is a disease characterized by the disruption of the normal bone vascular supply; it is a debilitating, painful, progressive, and refractory disease that has multiple etiologic risk factors.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2021

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Hyaluronic acid injections for treatment of pediatric sickle cell avascular necrosis of the humeral head

Wong

Shi

et al. 2021

Reg Anesth Pain Med

View full text Add to dashboard Cite

BackgroundAvascular necrosis (AVN) can impact up to 50% of patients with sickle cell disease (SCD) and can result in significant pain, decline in physical function and decreased quality of life. While hyaluronic acid (HA) has been used in the adult population for shoulder osteoarthritic pain, we present the first published pediatric case of HA injections in the glenohumeral joint, used to improve function and pain control.Case presentationThe patient is a 12-year-old woman with SCD, who suffered from chronic pain due to AVN of the humeral and femoral head. Despite engaging in a multidisciplinary pain management plan, she continued to have severe decline in physical functioning and became a wheelchair user. As a result, she was scheduled for a right total hip arthroplasty, which necessitated aggressive postoperative therapies using the glenohumeral joint. To improve this pain and to facilitate postoperative recovery, the patient underwent 4 weekly HA injections into the glenohumeral joint. Over a 2-month period, the patient was able to improve physical functioning, decrease opiate use and participate in all postoperative therapies.ConclusionConservative options to improve functioning and pain are especially important in pediatric patients where it may be desirable to delay surgical interventions until skeletal maturity. Our case report demonstrates the benefits of intra-articular HA as part of a multidisciplinary pain management plan to improve function and decrease pain related to AVN of the humeral head. Future studies should assess the long-term benefits of HA injections for AVN in the setting of SCD.

show abstract

Hyaluronic acid injections for treatment of pediatric sickle cell avascular necrosis of the humeral head

Wong

Shi

et al. 2021

Reg Anesth Pain Med

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Single US Guided HA Injection Reduced Hip Pain and Improved Function for 20 Months: A Case of Osteonecrosis

Abstract: BackgroundOsteonecrosis (ON) is a disease characterized by the disruption of the normal bone vascular supply; it is a debilitating, painful, progressive, and refractory disease that has multiple etiologic risk factors.

Cited by 1 publication

References 17 publications

Hyaluronic acid injections for treatment of pediatric sickle cell avascular necrosis of the humeral head

Hyaluronic acid injections for treatment of pediatric sickle cell avascular necrosis of the humeral head

Contact Info

Product

Resources

About